	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S103-PMC3235789	PMC3235789	12/2011	S103-PMC3235789	['the active form of Vitamin D (1,25-Dihydroxyvitamin D3) is a key modulator of the Immune Response, and Vitamin D is KNOWN to be a potent regulator of Placental Immunity, stimulating Antimicrobial Responses while suppressing inflammation [39].']	[('INCOMPLETE_EVIDENCE', 116)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 30, '1,25-dihydroxyvitamin D3'), ('GO_0006955', 'immune response', 82, 'immune response'), ('UBERON_0002405', 'immune system', 82, 'immune'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001987', 'placenta', 150, 'placental'), ('GO_0007566', 'embryo implantation', 160, 'immunity'), ('CHEBI_65381', 'albizoside C', 182, 'antimicrobial'), ('GO_0051607', 'defense response to virus', 182, 'antimicrobial responses')]
S4-PMC3277098	PMC3277098	12/2011	S4-PMC3277098	['THIS REVIEW explores the FINDINGS of epidemiological, clinical and laboratory research, and the POTENTIAL ROLE of Vitamin D in promoting the inappropriate Immune Responses which UNDERPIN the rise in a broad range of Immune diseases.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 178)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006955', 'immune response', 155, 'immune responses'), ('UBERON_0002405', 'immune system', 155, 'immune'), ('UBERON_0002405', 'immune system', 216, 'immune')]
S52-PMC3702245	PMC3702245	6/2013	S52-PMC3702245	['IMPACT on neonate and infant\nboth in vitro and observational studies have DEMONSTRATED that Vitamin D status during Pregnancy IMPACTS the Immune Response of the offspring.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0006955', 'immune response', 138, 'immune response'), ('UBERON_0002405', 'immune system', 138, 'immune')]
S32-PMC3717170	PMC3717170	5/2013	S32-PMC3717170	['with permission from christakos.60\n\nVitamin D in Immune function and disease PREVENTION\nmartin hewison (the david geffen school of medicine, university of california) detailed one of the most prominent of the SO-called nonclassical EFFECTS of Vitamin D: its ability to act as a potent modulator of Human Immune Responses.']	[('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 209), ('SUPERFICIAL_RELATIONSHIP', 232)]	3	[('CHEBI_28384', 'vitamin K', 36, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 36, 'Vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 298, 'human'), ('GO_0006955', 'immune response', 304, 'immune responses'), ('UBERON_0002405', 'immune system', 304, 'immune')]
S41-PMC3717170	PMC3717170	5/2013	S41-PMC3717170	['THUS, IT IS POSSIBLE that Vitamin D deficiency has a generalized DETRIMENTAL IMPACT on antibacterial responses and MAY THEREFORE play a ROLE in many types of infectious diseases.5an IMPORTANT NOTE by hewison is that current data SUGGEST that this particular Immune Response to Vitamin D is restricted to Primates, UNDERLINING a POTENTIAL ROLE for Vitamin D in the evolution of Primate Immunity, BUT also LIMITING the scope of FURTHER in vivo STUDIES to explore this activity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 229), ('PROBABLE_UNDERSTANDING', 314), ('INCOMPLETE_EVIDENCE', 328), ('SUPERFICIAL_RELATIONSHIP', 338), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 395), ('INCOMPLETE_EVIDENCE', 404), ('FUTURE_WORK', 426)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0006955', 'immune response', 258, 'immune response'), ('UBERON_0002405', 'immune system', 258, 'immune'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 304, 'primates'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 377, 'primate'), ('GO_0007566', 'embryo implantation', 385, 'immunity')]
S47-PMC3717170	PMC3717170	5/2013	S47-PMC3717170	['moreover, IT IS POSSIBLE that SOME diseases, such as leprosy and hiv infection, MAY BE ASSOCIATED with dysregulation of the core Vitamin D intracrine Immune mechanism, and MAY THEREFORE require higher circulating levels of 25(Oh)D3To reestablish normal Immune Responses.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 176)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0002405', 'immune system', 150, 'immune'), ('CHEBI_63755', 'o-nitrophenyl group', 223, '25(OH)D3to'), ('GO_0006955', 'immune response', 253, 'immune responses'), ('UBERON_0002405', 'immune system', 253, 'immune')]
S129-PMC3717170	PMC3717170	5/2013	S129-PMC3717170	['li and colleagues have isolated Monocytes from patients and examined Expression of a number OF Genes RELATED to Vitamin D Metabolism and Immune Responses.']	[('ANOMALY_CURIOUS_FINDING', 92), ('SUPERFICIAL_RELATIONSHIP', 101)]	2	[('CL_0000576', 'monocyte', 32, 'monocytes'), ('GO_0010467', 'gene expression', 69, 'expression'), ('SO_0000704', 'gene', 95, 'genes'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 112, 'vitamin D metabolism'), ('GO_0006955', 'immune response', 137, 'immune responses'), ('UBERON_0002405', 'immune system', 137, 'immune')]
S102-PMC3798907	PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]
S1540-PMC4113768	PMC4113768	7/2014	S1540-PMC4113768	['background: Vitamin D IS KNOWN to AFFECT Immune function; HOWEVER it is UNCERTAIN IF Vitamin D CAN alter the Immune Response towards the persistent herpesviruses, Ebv and Cmv.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('FULL_UNKNOWN', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 95)]	6	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('UBERON_0002405', 'immune system', 41, 'immune'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0006955', 'immune response', 109, 'immune response'), ('UBERON_0002405', 'immune system', 109, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'EBV'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'CMV')]
S2051-PMC4113768	PMC4113768	7/2014	S2051-PMC4113768	['evaluation of Vitamin D status in RELATION to Immune Response in children with Lower Respiratory Tract infections\n\ngori, m.; vierucci, f.; fanos, m.; del pistoia, m.; erba, p.; saggese, g.\nbackground: in addition to its KNOWN Skeletal EFFECTS, Vitamin D plays a ROLE in the Regulation of Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 262)]	4	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('GO_0006955', 'immune response', 46, 'Immune Response'), ('UBERON_0009567', 'nail of pedal digit', 79, 'Lower'), ('UBERON_0000061', 'anatomical structure', 85, 'Respiratory Tract'), ('UBERON_0004288', 'skeleton', 226, 'skeletal'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0065007', 'biological regulation', 274, 'regulation'), ('GO_0006955', 'immune response', 288, 'immune response'), ('UBERON_0002405', 'immune system', 288, 'immune')]
S2781-PMC4113768	PMC4113768	7/2014	S2781-PMC4113768	['EVIDENCE from other Tissues INDICATES that local Synthesis Of active Vitamin D (1,25-Dihydroxy Vitamin D; 1,25(Oh)2D3) INFLUENCES Immune Responses and in particular Tlr Signalling.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 119)]	3	[('UBERON_0000479', 'tissue', 20, 'tissues'), ('GO_0051610', 'serotonin uptake', 49, 'synthesis of ... vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 80, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 107, ',25(OH)2D3'), ('GO_0006955', 'immune response', 130, 'immune responses'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('GO_0031929', 'TOR signaling', 165, 'TLR signalling')]
S217-PMC4161853	PMC4161853	8/2014	S217-PMC4161853	['moreover, Gestational Vitamin A deficiency in Animal models HAS BEEN SHOWN to reduce the Intestinal Immune Response by decreasing the number of Immune Cells in Rat offspring [119] and Controlling the size of Secondary Lymph Organ and the efficiency of Immune Responses in the Adult Mouse offspring [120].']	[('INCOMPLETE_EVIDENCE', 60)]	1	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 46, 'animal'), ('UBERON_0000160', 'intestine', 89, 'intestinal'), ('GO_0006955', 'immune response', 100, 'immune response'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('CL_0000738', 'leukocyte', 144, 'immune cells'), ('UBERON_0002405', 'immune system', 144, 'immune'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 160, 'rat'), ('GO_0065007', 'biological regulation', 184, 'controlling'), ('UBERON_0005174', 'dorsal region element', 208, 'secondary lymph organ'), ('GO_0006955', 'immune response', 252, 'immune responses'), ('UBERON_0002405', 'immune system', 252, 'immune'), ('UBERON_0007023', 'adult organism', 276, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 282, 'mouse')]
S15-PMC4251419	PMC4251419	12/2014	S15-PMC4251419	['both uvr and Vitamin D (in its active form 1,25(Oh)2D, seefigure 1) have immunomodulatory EFFECTS [8] that provide a PLAUSIBLE mechanism whereby higher levels COULD decrease the risk of Autoimmune diseases (see section on mechanisms, below) and, through the same pathways, COULD impair the Immune Response to vaccination or infection [9,10].']	[('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 273)]	4	"[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_17996', 'chloride', 44, ','), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 45, '25(OH)2D'), ('UBERON_0001442', 'skeleton of manus', 186, 'autoimmune'), ('GO_0006955', 'immune response', 290, 'immune response'), ('UBERON_0002405', 'immune system', 290, 'immune')]"
S27-PMC4302429	PMC4302429	1/2015	S27-PMC4302429	['cells of the Immune System possess Vitamin D receptors and are capable of Metabolizing the active form of Vitamin D (1,25(Oh)2D3) [15], SUGGESTING Vitamin D as an IMPORTANT FACTOR in the Immune Response to Infection [16].']	[('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 163), ('SUPERFICIAL_RELATIONSHIP', 173)]	3	[('UBERON_0002405', 'immune system', 13, 'immune system'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0008152', 'metabolic process', 74, 'metabolizing'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 117, '1,25(OH)2D3'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0006955', 'immune response', 187, 'immune response'), ('UBERON_0002405', 'immune system', 187, 'immune'), ('GO_0007586', 'digestion', 206, 'infection')]
S161-PMC4302429	PMC4302429	1/2015	S161-PMC4302429	['clinical and experimental observations SUPPORT the HYPOTHESIS that Vitamin D has an EFFECT on the Immune Response to infection and the ability to eliminate pathogens after entry Into the host.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0006955', 'immune response', 98, 'immune response'), ('UBERON_0002405', 'immune system', 98, 'immune'), ('GO_0007631', 'feeding behavior', 178, 'into')]
S166-PMC4302429	PMC4302429	1/2015	S166-PMC4302429	['TO ASSESS the ROLE of Vitamin D in an in-vivo experimental MODEL of bacterial Cns infection, we analyzed the INFLUENCE of the infection on the survival and Immune Response of Mice Fed a diet containing different amounts of Vitamin D3 after injection of E. Coli directly into the right Frontal Lobe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 78, 'CNS'), ('GO_0006955', 'immune response', 156, 'immune response'), ('UBERON_0002405', 'immune system', 156, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 175, 'mice'), ('GO_0007631', 'feeding behavior', 180, 'fed'), ('CHEBI_33279', 'vitamin D5', 223, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 223, 'vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 253, 'E. coli'), ('UBERON_0016525', 'frontal lobe', 285, 'frontal lobe')]
S190-PMC4302429	PMC4302429	1/2015	S190-PMC4302429	['a study on the Immune Response to an allergic stimulus in Mice in vivo SUGGESTED that Vitamin D supplementation (100\xa0ng 1,25(Oh)2D injection) given after the initial period of sensitization prevented high levels of Eosinophils ASSOCIATED with a reduced local inflammatory response in Bronchoalveolar Lavage Fluid and Lung Tissue.']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 227)]	2	[('GO_0006955', 'immune response', 15, 'immune response'), ('UBERON_0002405', 'immune system', 15, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 58, 'mice'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 120, '1,25(OH)2D'), ('CL_0000771', 'eosinophil', 215, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 284, 'bronchoalveolar lavage fluid'), ('UBERON_0002048', 'lung', 317, 'lung tissue')]
S281-PMC4448820	PMC4448820	5/2015	S281-PMC4448820	['most of the EFFECTS of Vitamin A on Immune or inflammatory Responses CAN be EXPLAINED via binding of the Vitamin A Metabolite, Atra, to 1 of 3 zinc-finger proteins containing members of the Nuclear receptor superfamily, Rar-Α, Rar-Β, and Rar-Γ (185).']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('GO_0006955', 'immune response', 36, 'immune ... responses'), ('UBERON_0002405', 'immune system', 36, 'immune'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_39382', 'flufenoxuron', 115, 'metabolite'), ('CHEBI_17033', 'biliverdin', 127, 'ATRA'), ('GO_0005634', 'nucleus', 190, 'nuclear'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 220, 'RAR-α'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 227, 'RAR-β'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 238, 'RAR-γ')]
S289-PMC4448820	PMC4448820	5/2015	S289-PMC4448820	['ALTHOUGH NEW DATA ARE NEEDED to FURTHER ELUCIDATE the magnitude of these RELATIONS, IT IS CLEAR that Vitamin A has multiple Genetically MEDIATED EFFECTS on the Immune Response via the activities of atra.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 9), ('FUTURE_WORK', 9), ('FUTURE_WORK', 32), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 136), ('SUPERFICIAL_RELATIONSHIP', 145)]	9	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('SO_0000704', 'gene', 124, 'genetically'), ('GO_0006955', 'immune response', 160, 'immune response'), ('UBERON_0002405', 'immune system', 160, 'immune')]
S471-PMC4448820	PMC4448820	5/2015	S471-PMC4448820	['ALTHOUGH Vitamin A is absolutely REQUIRED for mounting an effective Immune Response, it is TEMPTING to SPECULATE that temporarily inhibiting Plasma Delivery Of Vitamin A to Tissues is beneficial to the host by creating a favorable environment for inflammation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0006955', 'immune response', 68, 'immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('GO_0070983', 'dendrite guidance', 148, 'delivery of vitamin A'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('UBERON_0000479', 'tissue', 173, 'tissues')]
S473-PMC4448820	PMC4448820	5/2015	S473-PMC4448820	['caption (boxed-text): text box 17\u2003\nPOSSIBLE mechanisms to EXPLAIN Vitamin A’s ROLE in Immune Response\n\n● vitamin A, via conversion to atra, can inhibit Nf-Κb Activation (118).']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0006955', 'immune response', 86, 'immune response'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('PR_000004370', 'asialoglycoprotein receptor 2', 113, 'A'), ('GO_0051092', 'positive regulation of NF-kappaB transcription factor activity', 152, 'NF-κB activation'), ('GO_0071159', 'NF-kappaB complex', 152, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 152, 'NF-κB')]
S593-PMC4448820	PMC4448820	5/2015	S593-PMC4448820	['HOWEVER, the EFFECTS of Vitamin A supplementation on the Immune System MAY lead TO variable clinical outcomes, DEPENDING ON the nature of the Immune Response NEEDED to combat the infecting pathogens.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('GO_0006955', 'immune response', 142, 'immune response'), ('UBERON_0002405', 'immune system', 142, 'immune')]
S782-PMC4448820	PMC4448820	5/2015	S782-PMC4448820	['caption (boxed-text): text box 27\u2003\nresearch priorities\n\n● accurate and stable biomarkers of vad\n● EFFECT of Vitamin A supplementation on inflammation and inflammatory markers\n● mechanisms behind the variable clinical outcomes SEEN as a result of the IMPACT of Vitamin A on the different Immune Responses\n● EFFECT of Vitamin A supplementation on neonates and infants <6 mo\n● INFLUENCE of zinc status on vaccine response\n● other CONFOUNDERS in the zinc–vaccine response ASSOCIATION (age, sex, degree of zinc deficiency, etc.)']	[('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 306), ('SUPERFICIAL_RELATIONSHIP', 374), ('PROBLEM_COMPLICATION', 427), ('SUPERFICIAL_RELATIONSHIP', 468)]	7	[('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin A'), ('GO_0006955', 'immune response', 287, 'immune responses'), ('UBERON_0002405', 'immune system', 287, 'immune'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin A')]
S74-PMC4514967	PMC4514967	12/2014	S74-PMC4514967	['first, ra can synergize with the activity of Tgf-Β to promote development of induced Foxp3+Tregcells,55,59–61ALTHOUGH it should be NOTED that neither the frequency nor number of Tregcells are reduced in Vitamin A–deficient Mice.62second, ra is REQUIRED to mount protective Immune Responses to infection by Organisms such as toxoplasma gondii .62third, Vitamin A–deficient Mice lack th17 cells63,64and display IMPAIRED th1 and th17 responses to t. gondii infection and oral administration of escherichia coli heat-labile enterotoxin.62vitamin A is also required for conditioning of Dcs and promoting the stereotypical phenotypic features of Intestinal Cd103+Dcs,58highlighting the fact that multiple cell types are Modulated by Vitamin A and underscoring the IMPORTANT ROLE it plays in Immunity.']	[('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 409), ('IMPORTANT_CONSIDERATION', 758), ('SUPERFICIAL_RELATIONSHIP', 768)]	6	[('PR_000000046', 'TGF-beta', 45, 'TGF-β'), ('PR_000017653', 'zinc finger protein ZFPM2', 85, 'FoxP3'), ('CL_0000960', 'T3 B cell', 91, 'Tregcells'), ('CL_0000960', 'T3 B cell', 178, 'Tregcells'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 223, 'mice'), ('GO_0006955', 'immune response', 273, 'immune responses'), ('UBERON_0002405', 'immune system', 273, 'immune'), ('NCBITaxon_1', 'root', 306, 'organisms'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 372, 'mice'), ('PR_000004370', 'asialoglycoprotein receptor 2', 542, 'A'), ('CL_0000990', 'conventional dendritic cell', 581, 'DCs'), ('UBERON_0000160', 'intestine', 640, 'intestinal'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 651, 'CD103'), ('CL_0000990', 'conventional dendritic cell', 657, 'DCs'), ('GO_0065007', 'biological regulation', 714, 'modulated'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin A'), ('GO_0007566', 'embryo implantation', 785, 'immunity')]
S394-PMC4896250	PMC4896250	4/2016	S394-PMC4896250	['a28 tgfβ1 level is ASSOCIATED with vdr Gene polymorphism in children with allergy diseases\n\ntatiana sentsova1, ilya vorozhko1, olga chernyak1, vera revyakina1, anna timopheeva1, andrey donnikov2\n\n1institute of nutrition;2dna-technology, jsc\n\ncorrespondence: tatiana sentsova – institute of nutrition, russia\nbackground: Vitamin D Receptor (Vdr) is Intracellulary located on the cells Of the Immune System and is INVOLVED in the Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 412)]	2	[('SO_0000704', 'gene', 39, 'gene'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 320, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 340, 'VDR'), ('GO_0005622', 'intracellular anatomical structure', 348, 'intracellulary'), ('CL_0000024', 'oogonial cell', 384, 'of'), ('UBERON_0002405', 'immune system', 391, 'immune system'), ('CL_0000034', 'stem cell', 398, 'system'), ('GO_0006955', 'immune response', 428, 'immune response'), ('UBERON_0002405', 'immune system', 428, 'immune')]
S6538-PMC4896250	PMC4896250	4/2016	S6538-PMC4896250	['conclusions: these results SUGGEST that Vitamin D MIGHT Modulate mediators INVOLVED in Immune Responses in crs.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 56, 'modulate'), ('GO_0006955', 'immune response', 87, 'immune responses'), ('UBERON_0002405', 'immune system', 87, 'immune')]
S17-PMC4979151	PMC4979151	8/2016	S17-PMC4979151	['VARIOUS in vitro STUDIES of the EFFECTS of Vitamin D on the T-Cell phenotype HAVE SHOWN that active Vitamin D3(1,25(Oh)2D3) suppresses Production Of Th1 Cytokines and Il-17 [12,13] and promotes Th2 Responses [14,15] and T Regulatory Cells (Treg) to maintain a balance and prevent exacerbated Immune Responses [16,17].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CL_0000084', 'T cell', 60, 'T-cell'), ('CHEBI_33279', 'vitamin D5', 100, 'vitamin D3'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 112, ',25(OH)2D3'), ('GO_0006915', 'apoptotic process', 135, 'production of Th1 cytokines'), ('PR_000001470', 'interleukin-28B', 167, 'IL-17'), ('GO_0007596', 'blood coagulation', 194, 'Th2 responses'), ('CL_0000902', 'induced T-regulatory cell', 220, 'T regulatory cells'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 220, 'T regulatory'), ('CL_0000901', 'Tr1 cell', 240, 'Treg'), ('GO_0006955', 'immune response', 292, 'immune responses'), ('UBERON_0002405', 'immune system', 292, 'immune')]
S190-PMC5129897	PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
S24-PMC5579643	PMC5579643	8/2017	S24-PMC5579643	['Nutrients, such as zinc and Vitamin D and nutritional factors, such as pre- and Probiotics, CAN INFLUENCE the nature of an Immune Response and are important in ensuring appropriate functioning of the Immune System, as described in the paragraphs below.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrients'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_26346', 'prostaglandins J', 80, 'probiotics'), ('GO_0006955', 'immune response', 123, 'immune response'), ('UBERON_0002405', 'immune system', 123, 'immune'), ('UBERON_0002405', 'immune system', 200, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 207, 'system')]
S129-PMC5679631	PMC5679631	11/2017	S129-PMC5679631	['in SUMMARY, the ROLE of Vitamin D is MOST LIKELY to Regulate the Immune Response to maintain Immune Homeostasis [25] by balancing activation of tolerance and the innate Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 42)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 52, 'regulate'), ('GO_0006955', 'immune response', 65, 'immune response'), ('UBERON_0002405', 'immune system', 65, 'immune'), ('GO_0055090', 'acylglycerol homeostasis', 93, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 93, 'immune'), ('GO_0007566', 'embryo implantation', 169, 'immune'), ('UBERON_0002405', 'immune system', 169, 'immune system')]
S130-PMC5679631	PMC5679631	11/2017	S130-PMC5679631	['ALTHOUGH Vitamin D promotes Immune tolerance, adequate Adaptive Immune Response, as measured by Igg Production in response to infection or vaccination, HAS BEEN observed in patients with relatively high Serum 25(Oh)D levels, SUGGESTING that Vitamin D maintains Immune stability by preventing excessive Immune Responses in EITHER direction [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 322)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('GO_0002250', 'adaptive immune response', 55, 'adaptive immune response'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('GO_0032608', 'interferon-beta production', 96, 'IgG production'), ('GO_0071735', 'IgG immunoglobulin complex', 96, 'IgG'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('UBERON_0002405', 'immune system', 261, 'immune'), ('GO_0006955', 'immune response', 302, 'immune responses'), ('UBERON_0002405', 'immune system', 302, 'immune')]
S31-PMC5716389	PMC5716389	9/2017	S31-PMC5716389	['Micronutrients\nseveral Micronutrients (Minerals or Vitamins) are KNOWN to be IMPORTANT in Fetal Immune System Development and child Immune Response to vaccines.table 1summarizes findings relevant to Immune functioning (zinc, Vitamin A, d, Folate, Iodine and Iron).']	[('INCOMPLETE_EVIDENCE', 65), ('IMPORTANT_CONSIDERATION', 77)]	2	[('CHEBI_34850', 'milrinone lactate', 0, 'Micronutrients'), ('CHEBI_33839', 'macromolecule', 23, 'micronutrients'), ('CHEBI_46751', 'quinolizidine', 39, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('UBERON_0000922', 'embryo', 90, 'fetal'), ('GO_0002520', 'immune system development', 96, 'immune system development'), ('UBERON_0002405', 'immune system', 96, 'immune system'), ('GO_0006955', 'immune response', 132, 'immune response'), ('UBERON_0002405', 'immune system', 132, 'immune'), ('UBERON_0002405', 'immune system', 199, 'immune'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 239, 'folate'), ('CHEBI_24859', 'iodine atom', 247, 'iodine'), ('CHEBI_24870', 'ion', 258, 'iron')]
S43-PMC5716389	PMC5716389	9/2017	S43-PMC5716389	['there is NO INFORMATION on the ASSOCIATION between maternal Vitamin A status during Pregnancy and infant Immune Response.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0006955', 'immune response', 105, 'immune response'), ('UBERON_0002405', 'immune system', 105, 'immune')]
S459-PMC5941617	PMC5941617	5/2018	S459-PMC5941617	['it HAS BEEN SUGGESTED that early-Life Vitamin D deficiency MAY CONTRIBUTE to the pathogenesis of childhood-onset cd by determining inappropriate Immune Responses, abnormal Intestinal Mucosal integrity and impaired local Defence against Microbial agents [413].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0000104', 'life cycle', 33, 'life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0006955', 'immune response', 145, 'immune responses'), ('UBERON_0002405', 'immune system', 145, 'immune'), ('UBERON_0001262', 'wall of intestine', 172, 'intestinal mucosal'), ('GO_0006952', 'defense response', 220, 'defence'), ('NCBITaxon_10088', 'Mus <genus>', 236, 'microbial')]
